No, I don't believe the university is waiting for the end of phase I Kevetrin trial. They are simply going through the red tape of the University to get it approved and started.
In Reply to 'To infinity and beyond!' the trial cannot move forward until there are decisions on K dosing. Will there be variable doses of K? varying times per week? We don't know
No Bologna till more known from phase 1 trial- that makes sense right?
News 
Market Data 
Discover 
AI
